Rocket Lab's defense contracts and backlog position it to benefit from national-security spending. Its $2.36B backlog includes over 100 booked launches, with an $816M SDA satellite deal and a $266M Space Force HASTE deal for hypersonic testing. Despite the Neutron delay, its $36B valuation offers one of the space sector's best risk-reward setups: exposure to the same defense and space-infrastructure trend as SpaceX at a fraction of its valuation. Rocket Lab is headed above $100. x.com 

Rocket Lab's growing Space Systems business positions it to provide more than launches for the space economy. It generated $189.5M in Q2, 81% of revenue; if its pending Iridium acquisition closes, it would gain a global satellite communications network. At about $51, this is one of the most compelling long-term opportunities in the space sector over 3-5 years, provided it keeps executing. Neutron's launch has slipped to 2027, and execution risks remain. x.com  x.com  x.com 

Rocket Lab's only 'moat' was Neutron, and its reported launch delay now amounts to cancellation for the investment case. The quoted report puts its inaugural launch in 2027; $2.99 is floated as a possible share price. x.com 

Rocket Lab's $266M US Air Force contract for 12 suborbital launches should boost the stock, and possibly the whole space sector. x.com 

Rocket Lab keeps executing: the US Space Force awarded it a $397M contract to build multiple advanced Flatellite spacecraft for the SB-AMTI program, which detects and tracks airborne threats in real time, and to launch them on Neutron. x.com 

Rocket Lab's delayed Neutron first flight pushes out a key part of its planned launch capacity. Flight one has moved to 2027, at least 1.5 years later than the previously indicated timing; the lack of clearer guidance is frustrating. The stock could fall 50% if it breaks key support, though that downside is conditional. x.com  x.com  x.com 

Rocket Lab's expanding contracted work improves medium- and long-term revenue visibility. Synspective added 20 dedicated Electron launches for 2028-31, bringing its total to 47; backlog reached $2.4 billion after more than $1 billion in Q2 and early-Q3 awards. Space Systems broadens the business beyond launches, while Neutron's medium-lift upside still depends on reaching operational orbit. x.com 

Rocket Lab is one of the very few public space companies with a real chance to compete alongside SpaceX, in a trillion-dollar space economy with room for several major winners as launch demand explodes. It posted a record quarter with a $2.2 billion backlog, won a $30 million Anduril contract, signed its largest launch agreement, was picked with Raytheon for the Space Force's Space-Based Interceptor program, and is acquiring Motiv Space Systems. x.com 

Rocket Lab still looks ridiculously expensive at 29 times forward sales against SpaceX at 22 times, even after a 65% fall. At 22 times, Rocket Lab would be roughly $38, and SpaceX would still be the pick. SpaceX also has better forward guidance; Rocket Lab's negative adjusted EBITDA makes sales multiples the valuation yardstick. x.com  x.com  x.com  x.com 

Rocket Lab is set up for a breakout as its technicals and fundamentals align. A W-bottom is forming, with price bouncing off $64.6 support. Q2 revenue hit a record $234 million, up 62% year over year, and backlog rose 137% to an all-time high of $2.36 billion. It won a $397 million Space Force SB-AMTI contract to build and launch Flatellites on Neutron and joined the $981 million NITE-STAR contract ceiling, showing it is a vertically integrated space company, not just a launch provider. x.com